Precision’s Messerschmidt Talks Immunotherapy with ASCO Post
Precision Oncology Chief Medical Officer Gerald Messerschmidt sits down to talk with ASCO Post‘s Ronald Piana regarding the future of immunotherapy. (more…)
Jena Discusses New PHE Preeclampsia Study With Orlando Sentinel
PHE Scientific Advisor Anupam Jena, coauthor of a new study on preeclampsia in the September issue of American Journal of Obstetrics & Gynecology, discussed the study’s findings and the growing economic impact of the condition with the Orlando Sentinel’s Amelia Cheatham. (more…)
Wilder on New Heart Drugs in MM&M: Drug Makers Need to Proactively Share Information With Payers
In a new article appearing in the latest MM&M, Precision for Value EVP and Managing Partner Kelly Wilder shares her perspective on the challenges of marketing new heart drugs. (more…)
Chad Clark Talks EU Expansion With Clinical OMICs
Precision for Medicine President Chad Clark speaks with Alex Philippides of Clinical OMICs to discuss Precision’s European expansion. (more…)
Precision’s Clark and Marshall Advocate for Biomarker Data Management in Bioscience Technology Online
Precision for Medicine’s Chad Clark, President, and Scott Marshall, Managing Director of Biomarker and IVD Analytics, contribute a new commentary for Bioscience Technology Online on the challenges of biomarker data management. (more…)
Precisioneffect’s Morgan Talks Work-Life Balance With Take the Lead
Carolyn Morgan, precisioneffect president, sits down with Take the Lead blogger Michele Weldon to discuss parental leave, the healthcare industry, parenting at work, and “beyonding.” (more…)
Precision for Medicine Expands Its Global Footprint for Oncology Development Services
Leadership in Place; Clinical Operations Teams Growing Throughout Europe
Bethesda, MD – July 6th, 2017 – Precision for Medicine today reported important progress in its global expansion plan. Precision for Medicine, with its oncology research team Precision Oncology, is rapidly expanding its global footprint to better serve clients developing oncology treatments. Investment in executive leadership and operational teams are underway across Europe, providing integrated, full-service clinical trial execution services throughout the continent. (more…)
Precisioneffect and Precision for Value Named to MM&M’s Top 100 Healthcare Agencies
Precision is pleased to announce that both precisioneffect and Precision for Value have been named to MM&M magazine’s Top 100 Healthcare Agencies for 2017. The agencies’ perennial inclusion on MM&M’s best list can be directly attributed to strong quantitative capabilities, outstanding creative, and industry-leading client retention. (more…)
Precision Oncology’s Messerschmidt in Managed Healthcare Executive Q&A: Innovative Strategies Help Fight Multiple Myeloma
In Managed Healthcare Executive, Precision Oncology Chief Medical Officer Dr. Gerry Messerschmidt discusses the many recent advances in treating multiple myeloma. (more…)
Precision’s Wilder in PM360: Common Pitfalls to Avoid to Ensure a Successful Product Launch
After spending millions on R&D just to get a product to market—and millions more promoting it—there’s nothing worse than when a launch falls flat. In a just-published panorama on PM360, Precision for Value’s Kelly Wilder identifies several critical mistakes that pharma companies make that can reduce the perceived value of a product in the marketplace. (more…)